O'Shaughnessy Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,156
Closed -$148K 2231
2024
Q3
$148K Buy
+14,156
New +$154K ﹤0.01% 1739
2024
Q2
Sell
-10,156
Closed -$120K 1985
2024
Q1
$120K Sell
10,156
-2,361
-19% -$30.2K ﹤0.01% 1579
2023
Q4
$178K Sell
12,517
-2,726
-18% -$31K ﹤0.01% 1432
2023
Q3
$185K Buy
15,243
+3,082
+25% +$39.8K ﹤0.01% 1299
2023
Q2
$153K Sell
12,161
-55
-0.5% -$653 ﹤0.01% 1250
2023
Q1
$135K Sell
12,216
-3,163
-21% -$39K ﹤0.01% 1249
2022
Q4
$188K Buy
15,379
+1
+0% +$11 ﹤0.01% 1126
2022
Q3
$161K Buy
15,378
+1,820
+13% +$20.3K ﹤0.01% 1108
2022
Q2
$146K Sell
13,558
-1,995
-13% -$16.4K ﹤0.01% 1076
2022
Q1
$147K Buy
15,553
+1,995
+15% +$18.7K ﹤0.01% 1106
2021
Q4
$157K Hold
13,558
﹤0.01% 1090
2021
Q3
$130K Sell
13,558
-2,047
-13% -$20.9K ﹤0.01% 1254
2021
Q2
$150K Hold
15,605
﹤0.01% 1156
2021
Q1
$154K Hold
15,605
﹤0.01% 1030
2020
Q4
$360K Buy
15,605
+15,550
+28,273% +$318K 0.01% 620
2020
Q3
$1K Hold
55
﹤0.01% 1735
2020
Q2
$1K Buy
+55
New +$670 ﹤0.01% 1591

Other funds holding FOLD

O'Shaughnessy Asset Management's FOLD Position: Q4 2024 in Review

O'Shaughnessy Asset Management sold out of Amicus Therapeutics (FOLD) in Q4 2024, closing a stake of 14,156 shares — an estimated $148K sold.

O'Shaughnessy Asset Management first reported a position in FOLD in Q2 2020 and held it in 17 quarters. The position peaked at $360K in Q4 2020. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.

  • O'Shaughnessy Asset Management reported no remaining Amicus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 14,156 Amicus Therapeutics shares in Q4 2024, an estimated $148K.
  • O'Shaughnessy Asset Management first reported a position in Amicus Therapeutics in Q2 2020 and held it in 17 quarters.
  • O'Shaughnessy Asset Management's Amicus Therapeutics position peaked at $360K in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.